Nucleotide Sequences
QTLs in Region (mRatBN7.2)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 1331732 | Srn4 | Serum renin concentration QTL 4 | 4.467 | renin activity (VT:0005581) | plasma renin activity level (CMO:0000116) | 1 | 35239598 | 78430678 | Rat | 631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 5925874 | 115540829 | Rat | 1357397 | Bw41 | Body weight QTL 41 | 4.19 | 0.0001 | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 22340647 | 49361612 | Rat | 1578650 | Bmd6 | Bone mineral density QTL 6 | 12.2 | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 1 | 509108 | 43284926 | Rat | 1578651 | Bmd7 | Bone mineral density QTL 7 | 14.2 | femur mineral mass (VT:0010011) | compact volumetric bone mineral density (CMO:0001730) | 1 | 509108 | 43284926 | Rat | 1358359 | Sradr1 | Stress Responsive Adrenal Weight QTL 1 | 4.74 | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 1 | 30882023 | 123479925 | Rat | 1331792 | Rf29 | Renal function QTL 29 | 4.589 | urine potassium amount (VT:0010539) | urine potassium level (CMO:0000128) | 1 | 35239598 | 78430678 | Rat | 2313062 | Bmd73 | Bone mineral density QTL 73 | 3.9 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 11481312 | 82174945 | Rat | 8552900 | Pigfal1 | Plasma insulin-like growth factor 1 level QTL 1 | 7.4 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 1 | 34836858 | 79836858 | Rat | 1554320 | Bmd1 | Bone mineral density QTL 1 | 12.2 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 1 | 509108 | 86060548 | Rat | 1354643 | Foco2 | Food consumption QTL 2 | 7.17 | 0.0001 | eating behavior trait (VT:0001431) | food intake rate (CMO:0000427) | 1 | 33449848 | 78449848 | Rat | 2313065 | Bss67 | Bone structure and strength QTL 67 | 3.1 | 0.0001 | tibia area (VT:1000281) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat | 7421626 | Bp360 | Blood pressure QTL 360 | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 4393289 | 49393289 | Rat | 1357400 | Bw62 | Body weight QTL62 | 4.05 | inguinal fat pad mass (VT:0010424) | inguinal fat pad weight to body weight ratio (CMO:0001253) | 1 | 22340647 | 67340647 | Rat | 1357401 | Bw43 | Body weight QTL 43 | 3.75 | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 22340647 | 49361612 | Rat | 2313069 | Bss68 | Bone structure and strength QTL 68 | 2.9 | 0.0001 | tibia size trait (VT:0100001) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat | 631495 | Bp96 | Blood pressure QTL 96 | 4.52 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 22340647 | 102268831 | Rat | 631494 | Bp95 | Blood pressure QTL 95 | 40 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 16206210 | 49268520 | Rat | 2313075 | Bss66 | Bone structure and strength QTL 66 | 3.4 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 11481312 | 82174945 | Rat | 5684998 | Bss101 | Bone structure and strength QTL 101 | 3.6 | tibia strength trait (VT:1000284) | tibia ultimate force (CMO:0001734) | 1 | 15431621 | 49361612 | Rat | 70225 | Bp58 | Blood pressure QTL 58 | 3.3 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32356093 | 162846471 | Rat | 5684999 | Bss102 | Bone structure and strength QTL 102 | 5.5 | 7e-07 | tibia strength trait (VT:1000284) | tibia stiffness (CMO:0001735) | 1 | 15431621 | 49361612 | Rat | 1300167 | Hrtrt2 | Heart rate QTL 2 | 4.35 | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 1 | 11481312 | 75088344 | Rat | 10059597 | Bp377 | Blood pressure QTL 377 | 3.42 | 0.025 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32737458 | 199368955 | Rat | 2313077 | Bss69 | Bone structure and strength QTL 69 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 11481312 | 82174945 | Rat | 1578756 | Iddm22 | Insulin dependent diabetes mellitus QTL 22 | 2.7 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 11835181 | 56835181 | Rat | 631508 | Sald1 | Serum aldosterone level QTL 1 | 3.7 | blood aldosterone amount (VT:0005346) | serum aldosterone level (CMO:0000487) | 1 | 9856001 | 54856001 | Rat | 1331785 | Rf27 | Renal function QTL 27 | 4.643 | urine sodium amount (VT:0006274) | urine sodium level (CMO:0000129) | 1 | 28879780 | 78430678 | Rat | 1300172 | Bp172 | Blood pressure QTL 172 | 3.56 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 1 | 32737273 | 90665040 | Rat | 724520 | Bp145 | Blood pressure QTL 145 | 2.1 | 0.0024 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 20784828 | 65784828 | Rat | 1558642 | Prcr2 | Prostate cancer resistance QTL 2 | 4.3 | prostate integrity trait (VT:0010571) | area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) | 1 | 20763158 | 44095856 | Rat | 2313092 | Bmd72 | Bone mineral density QTL 72 | 2.5 | 0.0001 | tibia mineral mass (VT:1000283) | total volumetric bone mineral density (CMO:0001728) | 1 | 11481312 | 82174945 | Rat | 2313097 | Bss70 | Bone structure and strength QTL 70 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat | 9589820 | Insglur3 | Insulin/glucose ratio QTL 3 | 10.75 | 0.001 | blood insulin amount (VT:0001560) | calculated plasma insulin level (CMO:0002170) | 1 | 34836858 | 79836858 | Rat | 738020 | Pia8 | Pristane induced arthritis QTL 8 | 4.7 | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 1 | 1 | 65833076 | Rat | 1600360 | Mcs16 | Mammary carcinoma susceptibility QTL 16 | 2.4 | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 1 | 2244390 | 43433040 | Rat | 1354599 | Bw29 | Body weight QTL 29 | 3.46 | 0.001 | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 33449848 | 78449848 | Rat | 1578669 | Bss9 | Bone structure and strength QTL 9 | 6.3 | femur morphology trait (VT:0000559) | bone trabecular cross-sectional area (CMO:0002311) | 1 | 509108 | 43284926 | Rat | 2302038 | Pia31 | Pristane induced arthritis QTL 31 | 5.5 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) | 1 | 10992065 | 55992065 | Rat | 8552948 | Pigfal11 | Plasma insulin-like growth factor 1 level QTL 11 | 4.7 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 1 | 34836858 | 79836858 | Rat | 634353 | Rends2 | Renal damage susceptibility QTL 2 | 0.05 | kidney blood vessel morphology trait (VT:0000530) | organ lesion measurement (CMO:0000677) | 1 | 19333571 | 56983283 | Rat | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Information